budenofalk 4 mg suppositories
dr. falk pharma gmbh - budesonide - suppository - budesonide
jorveza
dr. falk pharma gmbh - budesonide - esophageal diseases - antidiarrheals, intestinal antiinflammatory / antiinfective agents - jorveza is indicated for the treatment of eosinophilic esophagitis (eoe) in adults (older than 18 years of age).
applicator, <specify>
dr falk pharma australia pty ltd -
10172 - applicator,
budeson 3 mg capsules
rafa laboratories ltd - budesonide - capsules - budesonide 3 mg - budesonide - acute mild to moderate crohn’s disease with involvement of the ileum (twisted intestine) and/or ascending colon (part of large bowel). collagenous colitis.autoimmune hepatitis.
budeson 9 mg granules
rafa laboratories ltd - budesonide - granules gastro-resistant - budesonide 9 mg - budesonide - acute mild to moderate crohn’s disease with involvement of the ileium (twisted intestine) and/or ascending colon (part of large bowel).collagenous colitis.
budeson 9 mg granules
rafa laboratories ltd - budesonide - granules gastro-resistant - budesonide 9 mg - budesonide - acute mild to moderate crohn’s disease with involvement of the ileium (twisted intestine) and/or ascending colon (part of large bowel).collagenous colitis.
budeson 9 mg granules
rafa laboratories ltd - budesonide - granules gastro-resistant - budesonide 9 mg - budesonide - acute mild to moderate crohn’s disease with involvement of the ileium (twisted intestine) and/or ascending colon (part of large bowel).collagenous colitis.
jorveza 1 mg
rafa laboratories ltd - budesonide - tablets orodispersible - budesonide 1 mg - budesonide - treatment of eosinophilic esophagitis (eoe) in adults.
jorveza 0.5 mg
rafa laboratories ltd - budesonide - tablets orodispersible - budesonide 0.5 mg - budesonide - treatment of eosinophilic esophagitis (eoe) in adults.
ursofalk 250mg/5ml oral suspension
dr. falk pharma uk ltd - ursodeoxycholic acid - oral suspension - 50mg/1ml